6-Amino-1,3-dimethyl uracil (CAS 6642-31-5) Market
Global 6-Amino-1,3-dimethyl uracil (CAS 6642-31-5) market size in terms of revenue is projected to reach 76.06 Million USD by 2029 from 58.13 Million USD in 2023, with a CAGR 4.58% during 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.



6-Amino-1,3-dimethyluracil, assigned the chemical abstracts service (CAS) number 6642-31-5, is a substance distinguished by its molecular arrangement encompassing a uracil ring supplemented by amino and methyl components. It emerges as a byproduct of uracil, one of the essential nucleobases encountered in RNA. The systematic nomenclature of the compound delineates its constitution, wherein an amino group (NH2) is affixed to the sixth carbon atom of the uracil ring, accompanied by two methyl groups (CH3) positioned at the initial and third carbon atoms. This substance holds promise across diverse research domains, possibly due to its distinctive structural attributes and chemical responsiveness.

Report Sample includes:
- Table of Contents
- List of Tables & Figures
- Charts
- Research Methodology

Get FREE Sample of this Report at https://www.intelmarketresearch.com/download-free-sample/46/amino-dimethyl-uracil-cas




North America Market:

The North American market for 6-Amino-1,3-dimethyl uracil is expected to witness substantial growth during the forecast period from 2023 to 2029. Starting from an estimated value of 16.11 million USD in 2023, this market is projected to reach 19.84 million USD by 2029. This growth represents a Compound Annual Growth Rate (CAGR) of 3.53%. Factors contributing to this growth could include increasing applications of 6-Amino-1,3-dimethyl uracil in pharmaceuticals and chemical processes, as well as expanding research and development activities in the region.



Europe Market:

In Europe, the market for 6-Amino-1,3-dimethyl uracil is anticipated to experience notable expansion throughout the forecast period. The estimated market value is set to rise from 14.12 million USD in 2023 to approximately 17.80 million USD by 2029. This growth trajectory corresponds to a CAGR of 3.94%. The European market's growth might be driven by factors such as advancements in pharmaceutical manufacturing techniques and an increasing focus on specialized chemical synthesis.



Asia-Pacific Market:

The Asia-Pacific region is poised to witness significant growth in the 6-Amino-1,3-dimethyl uracil market. Starting from an estimated value of 22.36 million USD in 2023, the market is predicted to reach 31.23 million USD by 2029. This remarkable growth translates to a CAGR of 5.73%. The higher growth rate might be attributed to the region's booming pharmaceutical industry, ongoing research initiatives, and expanding industrial activities.



Latin America Market:

In Latin America, the market for 6-Amino-1,3-dimethyl uracil is expected to exhibit steady expansion. The market value is projected to increase from 2.73 million USD in 2023 to 3.58 million USD by 2029, indicating a CAGR of 4.62%. This growth can be influenced by factors such as increasing demand for pharmaceuticals and the adoption of advanced chemical synthesis methods in the region.



Middle East and Africa Market:

The Middle East and Africa region are also expected to experience growth in the 6-Amino-1,3-dimethyl uracil market. The estimated market value is set to rise from 2.81 million USD in 2023 to 3.61 million USD by 2029, with a CAGR of 4.26%. Factors contributing to this growth could include expanding pharmaceutical production capabilities and a growing emphasis on research and development activities.

Report Scope



This report aims to provide a comprehensive presentation of the global market for 6-Amino-1,3-dimethyl uracil, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding 6-Amino-1,3-dimethyl uracil.



The 6-Amino-1,3-dimethyl uracil market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global 6-Amino-1,3-dimethyl uracil market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.



For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.



The report will help the 6-Amino-1,3-dimethyl uracil manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Prominent manufacturers are:





In the year 2022, a significant trend emerged where the top five manufacturers collectively accounted for approximately 65.42% of the total revenue generated in the global 6-Amino-1,3-dimethyl uracil market. This concentration of revenue among a handful of key players signifies their substantial influence on the market dynamics, supply chain, and overall competitive landscape.

By Company



Hebei Guangxing Chemical
Aarti Pharmalabs
Xinhua Pharmaceutical
Shijiazhuang Kunxiangda Technology
Jinan Zhongke Yitong Chemical
Actylis (New Mountain Capital)
Capot Chemical
Dalian Allychem
Hubei Xinmingtai Pharm
Segment by Type



≥99%
<99%
Segment by Application



Plastic Plasticizer
Pharmaceutical Intermediate
Organic Synthesis
Production by Region



North America
Europe
China
India
Consumption by Region



North America
U.S.
Canada


Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia


Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe


South America
Mexico
Brazil
Rest of South America
Key Trends:



Surge in Pharmaceutical Industry Demand: The utilization of 6-Amino-1,3-dimethyl uracil in the synthesis of diverse pharmaceuticals, including antidepressants, anticonvulsants, and antineoplastic agents, is prompting an escalated demand from the pharmaceutical sector. The growing requirement for these therapeutic agents is a prime driver propelling the expansion of the 6-Amino-1,3-dimethyl uracil market.
Upward Trend in Cosmetics Industry Demand: The incorporation of 6-Amino-1,3-dimethyl uracil in the production of sunscreens and cosmetics is witnessing an upsurge. Heightened awareness about the detrimental effects of ultraviolet (UV) rays and the rising consumer demand for personal care products are fuelling the cosmetics industry's growth. This phenomenon, in turn, is spurring the demand for 6-Amino-1,3-dimethyl uracil.
Heightened Industrial Sector Demand: The inclusion of 6-Amino-1,3-dimethyl uracil in the synthesis of a multitude of chemicals and materials is resonating with amplified demand from the industrial sector. The escalating requisition for these essential components is propelling the industrial domain's expansion. Consequently, the demand for 6-Amino-1,3-dimethyl uracil is being catalyzed.
Innovation in Product Development: Prominent entities in the 6-Amino-1,3-dimethyl uracil market are persistently innovating to cater to the mounting demand across diverse applications. Their proactive pursuit of novel product offerings designed to satisfy the expanding demand for 6-Amino-1,3-dimethyl uracil is poised to serve as a catalyst for market growth in the forthcoming years.




Get the Complete Report & TOC at https://www.intelmarketresearch.com/chemicals-and-materials/46/amino-dimethyl-uracil-cas
CONTACT US:
276 5th Avenue, New York , NY 10001,United States
International: (+1) 646 781 7170
Email: help@intelmarketresearch.com

Follow Us On linkedin :- https://www.linkedin.com/company/24-market-reports
